In patients with schizophrenia, clozapine dosage is influenced by CYP1A2 activity, and tacrine metabolism is primarily dependent on the activity of CYP1A2 and CYP3A4 enzymes [53,54]. The gene discussed is CYP1A2; the disease is schizophrenia.